Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/15/2012 | CA2367291C Amplification of cyp24 and uses thereof |
05/15/2012 | CA2337082C Incorporation of exogenous lactic bacteria into the oral microflora |
05/15/2012 | CA2336174C Method for diagnosing an adenocarcinoma or a benign prostate pathology |
05/15/2012 | CA2313889C A system for detecting bacteria in blood, blood products, and fluids of tissues |
05/15/2012 | CA2288307C Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same |
05/15/2012 | CA2272842C Humanized anti-cd11a antibodies |
05/15/2012 | CA2219931C Stabilized standards and calibrators |
05/12/2012 | CA2754286A1 Holographic imaging based on time-domain data of natural-fiber containing materials |
05/10/2012 | WO2012061822A2 Materials and methods for mobilizing cells including cd34+, hematopoietic colony forming, and endothelial colony forming cells |
05/10/2012 | WO2012061797A2 On-chip 4d lightfield microscope |
05/10/2012 | WO2012061793A1 Serum mg53 as a diagnostic marker for tissue injury |
05/10/2012 | WO2012061786A1 Ice cleaved alpha-synuclein a biomarker |
05/10/2012 | WO2012061785A2 Ice inhibiting compounds and uses thereof |
05/10/2012 | WO2012061759A2 Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
05/10/2012 | WO2012061736A1 Circulating cytochrome c as biomarker of reperfusion injury and responsiveness to mitochondrial targeted interventions |
05/10/2012 | WO2012061719A2 Dna origami devices |
05/10/2012 | WO2012061626A1 A method of production, apparatus and system |
05/10/2012 | WO2012061578A2 Sperm motility analyzer and related methods |
05/10/2012 | WO2012061512A2 Methods and materials for assessing prognostic subtypes |
05/10/2012 | WO2012061405A2 Differential detection and quantification of oxalobacter |
05/10/2012 | WO2012061308A1 High-throughput assay methods and articles |
05/10/2012 | WO2012061291A2 Methods and compositions for cell separation of blood tissues |
05/10/2012 | WO2012061281A1 Diagnostic assays and methods of use for detection of filarial infection |
05/10/2012 | WO2012061129A1 Treatment of gastrointestinal inflammation and psoriasis a |
05/10/2012 | WO2012061100A2 Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis |
05/10/2012 | WO2012061073A1 Wound healing metakaryotic stem cells and methods of use thereof |
05/10/2012 | WO2012061068A2 Method of using a tracer for monitoring water treatment agents in a wet air scrubber |
05/10/2012 | WO2012060882A2 Interferometric detection using nanoparticles |
05/10/2012 | WO2012060760A1 Molecular marker for cancer |
05/10/2012 | WO2012060726A1 Process to detect defects in leather |
05/10/2012 | WO2012060704A1 Method and apparatus for examining eggs |
05/10/2012 | WO2012060636A2 Method for diagnosing stomach cancer |
05/10/2012 | WO2012060620A2 Anti-biofouling ssq/peg network and preparation method thereof |
05/10/2012 | WO2012060595A2 Structure with nanopore and apparatus for determining sequences of nucleic acids including the same |
05/10/2012 | WO2012060576A2 Method for processing a nano fine electrode within a biochemical analysis chip |
05/10/2012 | WO2012060483A1 Biosensor strip and strip reader |
05/10/2012 | WO2012060456A1 Blue-colored gold nanoparticles for immunological measurement, process for production of same, and measurement method using same |
05/10/2012 | WO2012060400A1 Body fluid component measurement device |
05/10/2012 | WO2012060315A1 Method for producing intestinal cells |
05/10/2012 | WO2012060163A1 Cell analyzer |
05/10/2012 | WO2012060109A1 Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease |
05/10/2012 | WO2012060025A1 Production of neutral antibody to human herpes virus 6 glycoprotein q1 and analysis thereof |
05/10/2012 | WO2012059835A1 A replaceable unit for use with an apparatus that determines the level of nitric oxide in exhaled breath |
05/10/2012 | WO2012059777A1 Lung tissue model |
05/10/2012 | WO2012059763A1 Biomarkers |
05/10/2012 | WO2012059750A2 Factors |
05/10/2012 | WO2012059703A1 In vitro or ex vivo method for storing and/or keeping an epidermis alive |
05/10/2012 | WO2012059653A1 Method and devices for analyzing components contained in the air |
05/10/2012 | WO2012059617A1 Method for obtaining useful data for diagnosing pancreatic cancer and for evaluating the response to treatment |
05/10/2012 | WO2012059616A1 Test predicting overall survival from pulmonary adenocarcinoma |
05/10/2012 | WO2012059615A1 Method for determining the production of reactive oxygen species in a cellular population |
05/10/2012 | WO2012059556A1 Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis |
05/10/2012 | WO2012059520A1 Spectroscopic finger-printing of raw materials |
05/10/2012 | WO2012059477A1 Prognosis and risk assessment of patients with non-specific complaints |
05/10/2012 | WO2012059425A1 A method of calibrating an air sensor |
05/10/2012 | WO2012059414A1 Magnetic cell detection |
05/10/2012 | WO2012059112A1 Development of medical products based on a new discovered function of red blood cells |
05/10/2012 | WO2012059083A2 Recovery immunoassay for the simultaneous immunochemical determination of an analyte (antigen) and a treatment antibody targeting the analyte |
05/10/2012 | WO2012058726A1 Markers of endothelial progenitor cells and uses thereof |
05/10/2012 | WO2012039756A3 Method of analyzing binding interactions |
05/10/2012 | WO2012035330A3 Vaccines against leptospira |
05/10/2012 | WO2012027288A3 Method for predicting and preventing cardiovascular disease |
05/10/2012 | WO2012026723A3 Method for detecting metal ions using unnatural activity of nucleic acid polymerase, and logic gate using same |
05/10/2012 | WO2012025759A3 Method |
05/10/2012 | WO2012024574A3 Small molecule arrays and methods for making and using them |
05/10/2012 | WO2012024439A3 Method and apparatus for electrocatalytic amplification on pre-oxidized measuring electrode |
05/10/2012 | WO2012021887A3 Biomarkers for the early detection of breast cancer |
05/10/2012 | WO2012021707A3 Premature-termination-codons readthrough compounds |
05/10/2012 | WO2012021045A3 Sentinel lymph node marker capable of multi-mode imaging |
05/10/2012 | WO2012019031A3 Biomarkers for growth hormone disorders |
05/10/2012 | WO2012015904A3 Biomarkers for prostate cancer and methods using the same |
05/10/2012 | WO2012015249A3 Method for screening diabetes treating agent |
05/10/2012 | WO2012012800A3 A method and apparatus for detecting the presence of anisotropic crystals and hemozoin producing parasites in liquid blood |
05/10/2012 | WO2012012748A3 Co-coupling to control reactivity of reagents in immunoassays |
05/10/2012 | WO2012012747A3 Chemical and physical degradation sensing in oil |
05/10/2012 | WO2012012284A3 Biosensor apparatuses and methods thereof |
05/10/2012 | WO2012011952A9 Copy number variant-dependent genes as diagnostic tools, predictive biomarkers and therapeutic targets |
05/10/2012 | WO2012010875A3 Diagnostic reagents |
05/10/2012 | WO2012009577A3 Monoclonal antibodies against pcbp-1 antigens, and uses therefor |
05/10/2012 | WO2012006084A3 Systems and methods for transfer of liquid samples |
05/10/2012 | WO2012003030A3 Methods of identifying & using anti-viral compounds |
05/10/2012 | WO2011161420A3 Coincidence detection |
05/10/2012 | WO2011146749A4 Testing method and kit for detecting lead, mercury and chromate in paint, varnish and other surface coatings |
05/10/2012 | WO2011146439A3 Identifying antifungal agents that inhibit iaa or a yap family member |
05/10/2012 | WO2011139854A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
05/10/2012 | WO2011139853A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
05/10/2012 | WO2011133477A3 Compositions and methods for prediction of drug sensitivity, resistance, and disease progression |
05/10/2012 | WO2011132941A3 Tf-bpb specifically binding to transcription factor |
05/10/2012 | WO2011132086A3 Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof |
05/10/2012 | WO2011122864A3 Method for determining genotoxicity using non-fluorescent proteins |
05/10/2012 | WO2011117084A8 Diagnostic assay for obesity and related disorders |
05/10/2012 | WO2011110359A8 Stat3 activation inhibitors |
05/10/2012 | US20120117692 Constitutive Expression Cassettes for Regulation of Plant Expression |
05/10/2012 | US20120117676 Soybean Event 127 and Methods Related Thereto |
05/10/2012 | US20120117672 Isolation and growth of stem cells from hemangiomas |
05/10/2012 | US20120117671 Steatohepatitis-liver cancer model animal |
05/10/2012 | US20120117670 Humanized axl antibodies |
05/10/2012 | US20120117669 Human antibodies derived from immunized xenomice |
05/10/2012 | US20120117668 Nucleic acid expression construct and its use as a cell proliferation marker |
05/10/2012 | US20120116683 Highly selective chemical and biological sensors |